More specifically, human epidermal growth factor receptor 2 (HER2) is linked to breast cancer, alpha-fetoprotein to hepatocellular carcinoma, and the increased expression of epidermal growth factor receptor (EGFR) on EVs correlates with a higher risk of non-small cell lung cancer 32. Here, ERBB2 is linked to non-small cell lung carcinoma.